Arbutus Biopharma ABUS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q3 | 3.85 | 107 | -17.19 | -20 | -13.12 | 140 |
| 2024Q2 | 3.09 | 122 | -16.70 | -20 | -12.76 | 160 |
| 2024Q1 | 2.58 | 115 | -16.20 | -18 | -12.13 | 150 |
| 2023Q4 | 2.50 | 106 | -17.14 | -19 | -12.75 | 144 |
| 2023Q3 | 2.03 | 119 | -15.83 | -20 | -11.99 | 159 |
| 2023Q2 | 2.30 | 135 | -12.27 | -17 | -9.29 | 177 |
| 2023Q1 | 3.03 | 144 | -11.64 | -16 | -8.45 | 191 |
| 2022Q4 | 2.33 | 137 | -15.53 | -22 | -10.99 | 195 |
| 2022Q3 | 1.91 | 146 | -11.76 | -18 | -8.37 | 204 |
| 2022Q2 | 2.71 | 153 | -8.90 | -14 | -6.27 | 216 |
| 2022Q1 | 2.98 | 166 | -9.40 | -16 | -7.14 | 237 |
| 2021Q4 | 3.89 | 169 | -14.23 | -21 | -11.52 | 204 |
| 2021Q3 | 4.29 | 130 | -16.59 | -19 | -12.73 | 166 |
| 2021Q2 | 3.03 | 101 | -18.04 | -19 | -13.77 | 135 |
| 2021Q1 | 3.33 | 114 | -15.16 | -16 | -11.56 | 146 |
| 2020Q4 | 3.55 | 102 | -17.10 | -17 | -12.71 | 137 |
| 2020Q3 | 3.13 | 97 | -23.03 | -19 | -16.40 | 131 |
| 2020Q2 | 1.82 | 66 | -20.30 | -14 | -14.07 | 98 |
| 2020Q1 | 1.01 | 73 | -18.99 | -14 | -13.32 | 103 |
| 2019Q4 | 2.78 | 73 | -31.53 | -25 | -22.13 | 106 |